Trump’s claim that malaria drug can treat coronavirus may be premature

Agency News

Scientists and infectious disease experts say Trump’s claims about the drugs — chloroquine and hydroxychloroquine — may be a bit premature.

Last week, Trump announced at a White House press briefing last week that two anti-malaria drugs were a “game-changer” that have shown “very, very encouraging results.″

Experts added that large clinical trials are needed to determine whether the drugs are truly effective in fighting COVID-19. To win approval for widespread use, chloroquine and azithromycin will need to undergo rigorous clinical trials with thousands of participants — not a couple dozen, according to the FDA agency’s guidelines.